Obesity – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033
Obesity is a metabolic disorder characterized by an excess accumulation of fatty tissue. Its categorization hinges on measuring the body mass index (BMI), a ratio involving a person's weight and height. This calculation helps to categorize health risks tied to obesity within a population. A BMI surpassing 30 kg/m^2 is identified as indicative of obesity, further breaking down into class 1 (30 to 34.9 kg/m^2), class 2 (35 to 39.9 kg/m^2), and class 3 or severe obesity (≥ 40 kg/m^2). Obesity can have significant health implications, increasing the risk of various medical issues, including:
1.
Cardiovascular Ailments: Obesity significantly
heightens the likelihood of conditions such as heart disease, hypertension, and
stroke. Excessive body fat accumulates fatty deposits in arteries, constraining
blood flow and elevating the risk of heart-related issues
2.
Type 2 Diabetes: A strong association exists
between obesity and the onset of type 2 diabetes. Excess fat interferes with
the body's ability to utilize insulin, efficiently elevating blood sugar levels
3.
Joint Challenges: The surplus weight places
added pressure on joints, contributing to osteoarthritis and persistent joint
discomfort
4.
Respiratory Problems: Obesity can contribute
to breathing difficulties, including sleep apnea and obesity hypoventilation
syndrome, exacerbating overall well-being
5.
Cancer: Specific cancer types, like breast,
colon, and pancreatic cancer, have been linked to obesity
6.
Mental Well-being: The impact of obesity on
mental health and overall wellness is apparent, often inducing issues such as
depression, anxiety, and low self-esteem, often due to societal bias and
concerns related to body image
7.
Liver Disorder: Non-alcoholic fatty liver
disease (NAFLD) commonly stems from obesity and can advance to more severe
conditions such as non-alcoholic steatohepatitis (NASH) and cirrhosis
8.
Reproductive Health: Obesity can lead to
hormonal imbalances that negatively affect reproductive health, leading to
irregular menstrual cycles, fertility challenges, and complications during
pregnancy
9.
Kidney Ailments: Obesity is correlated with an
escalated risk of kidney disease and eventual kidney failure
10.
Gastrointestinal Problems: Obesity contributes
to gastroesophageal reflux disease (GERD) and other digestive disorders
Beyond its
physical consequences, obesity can erode the quality of life and give rise to
psychological issues such as depression and diminished self-esteem. Liraglutide
stands as the sole glucagon-like peptide-1 receptor agonist (GLP-1RA) endorsed
for treating obesity in individuals without diabetes.
·
In the United States, 41.9% of adults and
19.7% of adolescents and children individuals, are afflicted by obesity.
Thelansis’s
“Obesity Market Outlook, Epidemiology, Competitive Landscape, and Market
Forecast Report – 2023 To 2033" covers disease overview, epidemiology,
drug utilization, prescription share analysis, competitive landscape, clinical
practice, regulatory landscape, patient share, market uptake, market forecast,
and key market insights under the potential Obesity treatment modalities
options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan,
and China).
KOLs insights of Obesity across 8 MM
market from the centre of Excellence/ Public/ Private hospitals participated in
the study. Insights around current treatment landscape, epidemiology, clinical
characteristics, future treatment paradigm, and Unmet needs.
Obesity
Market Forecast Patient Based Forecast Model (MS. Excel Based Automated
Dashboard), which Data Inputs with sourcing, Market Event, and Product Event,
Country specific Forecast Model, Market uptake and patient share uptake,
Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario,
Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice
has been established based on a deep understanding of the pharma/biotech
business environment to provide an optimized support system to all levels of
the decision-making process. It enables business leaders in forward-thinking
and proactive decision-making. Thelansis supports scientific and commercial
teams in seamless CI support by creating an AI/ ML-based technology-driven
platform that manages the data flow from primary and secondary sources.
Tags: Obesity, Obesity
market outlook, Obesity competitive landscape, Obesity market forecast, Thelansis, Primary market research, KOL
insights, Competitive Intelligence (CI)
Comments
Post a Comment